Advances in oncology have been instrumental in improving outcomes of patients with cancer. CART cellular therapies have arguably changed the way we care for hematologic malignancies forever, but the logistics of administering CART have challenged how applicable this therapy could be to all eligible patients.
I sit down with the amazing Dr. Navneet Majhail, Director of Bone Marrow Transplant at the Cleveland Clinic and President of the Society of Marrow Transplantation 2019-2020 and discuss logistics of CART administration and what can be done to mitigate barriers to successful therapy. You want to listen to this one if you have any interest in CART, and how can you not.
This podcast is produced by the Journal of Clinical Pathways.
Dr. Joe Mikhael, Chief Medical Officer of the International Myeloma Foundation (IMF) and Professor at TGen, takes us beyond his medical career to explore the personal experiences that have shaped his journey in oncology. Dr. Mikhael discusses the IMF’s targeted strategies for reducing health disparities among diverse ethnic and racial groups affected by myeloma, shedding
Tom Beer, Chief Medical Officer of the Multi-Cancer Early Detection (MCED) program at Exact Sciences, delves into the groundbreaking science behind MCED tests, which use advanced biomarkers for early detection of multiple cancer types. On this Healthcare Unfiltered episode, he explains who may be eligible for these tests, how to interpret results to avoid unnecessary
In this special episode, I give up the microphone to guest host Kelly Ryerson, who takes over the show asking questions about my new book “The Cancer Journey.”
